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complications. The protease inhibitors cause extensive inhibition of the cytochrome P450 system that result in a profound extension of many anaesthetic drug half-lives. In addition the PI have a host of metabolic complications including lipodystrophy, insulin resistance and dyslipidemia, which result in patients at a higher risk for cardiovascular morbidity and mortality.
Anaesthetic management of the patients are discussed and the importance of enforcing universal precautions together with ensuring that ARV dosing schedules are maintained is emphasised. An aspect of great concern which is also touched on is post-exposure prophylaxis and in particular the implications when the patient has been on ARV's and may be carrying a resistant strain of HIV.
